Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

20.66
Delayed Data
As of Apr 21
 0.00 / 0.00%
Today’s Change
7.84
Today|||52-Week Range
37.69
+16.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$130.0M

Company Description

Albireo Pharma, Inc. is a pharmaceutical company engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions. The company was founded by Jan Mattsson on December 8, 2003 and is headquartered in Boston, MA.

Contact Information

Albireo Pharma, Inc.
50 Milk Street
Boston Massachusetts 02109
P:(857) 415-4774
Investor Relations:

Employees

Shareholders

Other institutional2.71%
Individual stakeholders1.94%
Mutual fund holders0.75%

Top Executives

Ronald H. CooperPresident, Chief Executive Officer & Director
Jan Peter MattssonChief Operating Officer
Michael J. GutchCFO, Director & Chief Business Officer
Paresh N. SoniChief Medical & Scientific Officer
Kristina TorfgårdVice President-Clinical & Regulatory Affairs